genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Mitsubishi Tanabe Pharma
Drug Discovery
Mitsubishi Tanabe to Buy Parkinson’s Disease Drugs Firm NeuroDerm for $1.1B
Industry News
Forum Pharmaceuticals to Restructure after Phase III Failures
Drug Discovery
Mitsubishi Tanabe Gains Partial Asian Rights to Regeneron’s Fasinumab for Up to $325M
Drug Discovery
Covagen, Tanabe Expand Fynomer Therapeutics Collab
Drug Discovery
Mitsubishi Tanabe Buys Medicago for $357M
Cancer
OncoEthix Gains Rights to Mitsubishi Tanabe’s Anticancer Bromodomain Inhibitor
News
Synageva, Mitsubishi Tanabe Pharma Add Second Rare Disease Program to Alliance
Drug Discovery
Medicago Gets C$3M Up Front from Mitsubishi Tanabe Pharma in Vaccine Deal
News
Odyssey Thera to Use GE Healthcare’s Imaging System
News
Mitsubishi Tanabe Expands Commercial Rights to Vertex’ HCV Candidate with $105M Up Front
1
2
Page 1 of 2
Scroll Up
Scroll Up
